Please login to the form below

Not currently logged in
Email:
Password:

TiGenix

This page shows the latest TiGenix news and features for those working in and with pharma, biotech and healthcare.

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Alofisel, which works by a local administration of allogeneic expanded adipose-derived stem cells (eASCs), was initially manufactured at Belgian biopharma TiGenix, which entered into a licensing agreement with Takeda. ... TiGenix has another

Latest news

More from news
Approximately 5 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    A few days later Takeda announced it was paying $628m (82% share price premium) to buy Belgian company TiGenix NV and its lead asset Cx601 (darvadstrocel), an allogeneic stem cell therapy ... Option exercise (2 options). 640. TiGenix/Takeda. Cx601, lead

  • Deal Watch July 2016 Deal Watch July 2016

    Other deals where the licensee has committed real upfront money include Takeda's $28m upfront payment for ex-US rights to TiGenix's Cx601, a suspension of allogeneic adipose-derived stem ... Acquisition. 416. TiGenix/ Takeda. Cx601 - Stem cell treatment

  • Pharma deals in July 2015 Pharma deals in July 2015

    At the most extreme in terms of a low upfront is the $7m paid by Tigenix in the $293m acquisition of Coretherapix, presumably because stem cell therapies are high risk. ... Coretherapix / Tigenix. Company acquisition. Cardiac stem cell in Phase 2.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Bone Therapeutics strengthens board with new chairman Bone Therapeutics strengthens board with new chairman

    Jean Stéphenne joins the cell therapy company from TiGenix. Belgian biotechnology company Bone Therapeutics has appointed Jean Stéphenne as its new chairman of the board of directors, succeeding Steve Swinson in ... Stéphenne’s career history has

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    Belgium biopharma firm TiGenix has appointed Dr Gregory Gordon to head up its US medical department as part of moves to strengthen its stateside operations. ... Meanwhile, Valles-Sukkar arrives at TiGenix from Alexion Pharmaceuticals, where she was

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    TiGenix CEO appointed president of the EBE’s board of directors. The European Biopharmaceutical Enterprises (EBE) has appointed Eduardo Bravo as president of its board of directors for the 2016-2018 ... He c urrently serves as chief executive officer

  • TiGenix appoints Dr Marie Paule Richard TiGenix appoints Dr Marie Paule Richard

    Belgium-based cell therapy company TiGenix has appointed Dr Marie Paule Richard as its new chief medical officer. ... We are very fortunate to have biopharma development, regulatory and commercialisation heavyweight Marie Paule joining the TiGenix

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics